Taken together, future studies are warranted to investigate the further molecular mechanisms in terms of the BBR’s anti-tumorigenic effect to enhance chemosensitivity to Gem against PDAC cells, including the validation in the Gem-R tumor-derived organoids and animal models. The gene discussed is GEM; the disease is neoplasm.